semaglutide for animals Weight loss drugs cats? Company launches clinical trial of GLP-1 implants in cats Pet Safety Alert: Rising GLP-1

The analysis of secondary CV outcomes showed that nonfatal stroke was also significantly lower in the dulaglutide group compared with placebo (2.7% vs 3.5%, P = .017), however, dulaglutide did not show any effects on all-cause mortality ( P = .067)

[DOI] [PMC free article] [PubMed] [Google Scholar] 106.MENON A V, LIU J, TSAI H P, et al

Key variants like GLP1R rs6923761 and GIPR rs1800437 determine the density and sensitivity of receptors that tirzepatide targets

Factors that influence outcomes include starting weight, metabolic health, adherence to dietary recommendations, physical activity level, and individual medication response

People with diabetes are at risk for not only diabetic retinopathy but also the development of conditions, such as cataracts, glaucoma and dry eye